YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease

Siyang Ye1, Meng Zhang1, Xunhua Zheng1

  • 1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, 510080, China.

Redox Biology
|November 28, 2024
PubMed

Insights

In diabetic kidney disease (DKD), inactivated yes-associated protein 1 (YAP1) disrupts mitochondrial quality control (MQC) in kidney tubule cells, worsening injury. Restoring YAP1 function ameliorates DKD progression and kidney damage.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Mitochondrial Biology

Background:

  • Diabetic kidney disease (DKD) involves renal tubule cell injury and mitochondrial dysfunction.
  • Mitochondrial quality control (MQC) is crucial for maintaining cellular health in renal tubules.
  • Dysfunctional MQC is linked to progressive kidney dysfunction in DKD.

Purpose of the Study:

  • To investigate the role of yes-associated protein 1 (YAP1) inactivation in MQC dysregulation within renal tubule cells in DKD.
  • To explore the diagnostic potential of YAP1 and MQC-related genes in DKD.
  • To elucidate the mechanisms by which YAP1 influences MQC and kidney injury in DKD.

Main Methods:

  • Bioinformatic analysis of Gene Expression Omnibus (GEO) transcriptomics data.
  • Receiver operating characteristic (ROC) curve analysis.
  • In vitro studies using cultured renal tubule cells exposed to high glucose and palmitic acid.
  • In vivo studies using diabetic mouse models with targeted Yap1 deletion or YAP1 activator administration.
  • Analysis of kidney biopsy samples from DKD patients.

Main Results:

  • YAP1 inactivation and MQC dysregulation were observed in DKD subjects, cultured cells, and patient kidney tissues.
  • YAP1 and MQC genes showed high diagnostic accuracy for DKD.
  • Renal tubule-specific Yap1 deletion exacerbated kidney injury, disrupted MQC, and increased C-X-C motif chemokine ligand 1 (CXCL1) secretion.
  • YAP1 activation ameliorated DKD progression and reduced CXCL1 secretion in mice.
  • YAP1 overexpression in vitro maintained mitochondrial function and suppressed CXCL1 production.

Conclusions:

  • Tubule YAP1 inactivation is a key driver of MQC dysfunction in DKD progression.
  • YAP1 inactivation promotes M1 macrophage polarization via CXCL1, contributing to kidney injury.
  • Targeting YAP1 represents a potential therapeutic strategy for DKD.